Meta-analysis of second-trimester markers for trisomy 21.
about
Aberrant right subclavian artery in fetuses with Down syndrome: a systematic review and meta-analysisNasal bone length: prenasal thickness ratio: a strong 2D ultrasound marker for Down syndrome.Sonographic markers for early diagnosis of fetal malformations.Prenatal Screening Using Maternal Markers"Down syndrome: an insight of the disease"The practice patterns of second trimester fetal ultrasonography: A questionnaire survey and an analysis of checklistsPrevalence of defined ultrasound findings of unknown significance at the second trimester fetal anomaly scan and their association with adverse pregnancy outcomes: the Welsh study of mothers and babies population-based cohortSystematic review and meta-analysis of performance of second-trimester nasal bone assessment in detection of fetuses with Down syndrome.Systematic review of the clinical prediction rules for the calculation of the risk of Down syndrome based on ultrasound findings in the second trimester of pregnancy.Role of the second-trimester 'genetic sonogram' for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing.Second-trimester fetal aberrant right subclavian artery: original study, systematic review and meta-analysis of performance in detection of Down syndrome.Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and GynScreening for Down syndrome.Fetal Aortic Arch Anomalies: Key Sonographic Views for Their Differential Diagnosis and Clinical Implications Using the Cardiovascular System Sonographic Evaluation Protocol.The recurrence of sonographic 'soft markers': ominous sign or 'just' genetics?Aberrant Right Subclavian Artery: Correlation Between Fetal and Neonatal Abnormalities and Abnormal Genetic Screening or Testing.Incidence of an Aberrant Right Subclavian Artery on Second-Trimester Sonography in an Unselected Population.Nasal bone length, prenasal thickness, prenasal thickness-to-nasal bone length ratio and prefrontal space ratio in second- and third-trimester fetuses with Down syndrome.Fetal facial profile markers of Down syndrome in the second and third trimesters of pregnancy.Mild fetal cerebral ventriculomegaly: prevalence, characteristics, and utility of ancillary testing in cases presenting to a tertiary referral center.QUAD versus cfDNA in an urban population in the second trimester for detection of trisomy 21: a cost sensitivity analysis.Echogenic intracardiac focus on second trimester ultrasound: prevalence and significance in a Middle Eastern population.Genetic Counseling and Prenatal Diagnosis of Triploidy During the Second Trimester of PregnancyNew osseous soft markers for trisomy 13, 18 and 21.Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.Variability Over Time of Normal-Sized Fetal Renal Pelvis During the Second Trimester Scan.What is the importance of second-trimester "soft markers" for trisomy 21 after an 11- to 14-week aneuploidy screening scan?Impact of gestational age on nuchal fold thickness in the second trimester.Chromosomal microarray analysis in fetuses with aberrant right subclavian artery.The utilization of circulating cell-free fetal DNA testing and decrease in invasive diagnostic procedures: an institutional experience.Maxillary length in euploid and aneuploid fetuses.Rational and irrational ratios.Isolated intracardiac echogenic focus on routine ultrasound: implications for practice.Fetal ultrasound examination and assessment of genetic soft markers in Sweden: are ethical principles respected?Swedish University Students' Opinion Regarding Information About Soft Markers.The cavum septi pellucidi in euploid and aneuploid fetuses.Absent fetal nasal bone in the second trimester and risk of abnormal karyotype in a prescreened population of Chinese women.Facial markers in second- and third-trimester fetuses with trisomy 18 or 13, triploidy or Turner syndrome.Ultrasonographic fetal soft markers in a low-risk population: prevalence, association with trisomies and invasive tests.Prefrontal space ratio in second- and third-trimester screening for trisomy 21.
P2860
Q27023556-7F640B45-8DAD-4338-98E8-2FC15C520C8EQ35008564-3F5F91D8-15BC-4203-B9C5-921DB5030CAFQ35030149-DFB8F127-F739-4C7D-B7E1-66E2FE654DD3Q35667300-85D3A883-CF62-4BB2-8C21-81A7981396DAQ35730155-9B45F659-2B08-41B6-97A8-7C89431F2DCEQ36328623-F95F9514-9BA6-4DD5-94B3-0EE8451D51C9Q37105243-6300FDF3-526E-49D2-A655-542FE64C69F3Q38154860-0FCC252C-1DCE-442A-BDD8-6C196A3E0BFCQ38178203-A5B6E91D-AC14-4D48-8215-B92B00F4361FQ38179321-19281D12-7544-420E-A2ED-80EF4E299B6AQ38192551-8DC270BF-44F5-44A7-9282-0110CCBBCDA2Q38207002-5655DB45-A951-4843-927D-81E6E358EFC7Q38235996-4268FD82-AAD5-497E-9447-AEE813F46F2FQ38682643-9E7C45DA-F42E-4E93-8759-F5C3FEE1D9F6Q38917458-4B80C47F-0F3E-48CA-89D8-D0B3E5ECEB57Q39029385-1AD875BF-11E0-45AD-B1BE-8E9CC27640B7Q39160854-D1D71A9A-56A1-42D4-8EFE-C3C4B1B03479Q40186086-09CDCC9F-1C6C-49D3-8B89-1233DF449AF7Q40232555-8DFE54E8-8D86-48CB-88F2-38ECD6F7EA43Q40239929-035F62FB-C7B2-4C1A-8B95-FC88DC55B3A6Q40413919-570CB176-8771-4F55-9614-B542AB44FB73Q40537875-F5A4423D-12A9-4453-9C8E-594C4DF6F957Q41021820-3FDC7CB1-B10C-4424-8F37-C6175CB4EA84Q41086957-96798E0E-810D-4DC6-96D5-BA10C330D456Q41235376-906F852A-8446-47A7-A304-B4B5CFB9A387Q41687607-986C8EDD-6DB5-4B6C-BB37-185E470CD545Q43424745-19C6897B-30EE-4165-9F75-283E8BA89D2AQ43493066-49C8E0CA-8CF4-4B64-AADD-AFA00B422D2AQ43704081-B7CACEFC-B05D-414B-A2BF-B6DADA1D0035Q45998316-56DBBE93-161F-433F-AE77-5E176DAAD135Q47616678-E857EA0A-DC35-4479-9906-F7D4857500A9Q47724835-F7105426-4093-4B11-A47A-B11BE95560DDQ47740636-724DD0CC-2E26-4286-9FD1-D0AFD157D0FAQ48056782-85BE1A28-DF28-49BE-A5CD-B93EF22DC04DQ48160076-1E8A34B8-45A5-40AB-A205-AD71033A7F20Q48218505-8FC14A25-DC46-4A41-BCF8-A231DC894404Q48257060-CCF36FD8-61DB-4E0A-AEA7-9F84CDBFB89BQ48273971-52B3B6D4-1FD0-4F00-996F-E4F412BE2ED7Q50732804-66EEADA7-B687-4072-9F21-F96987D256C4Q50928272-0BB661B3-1AE1-429B-A700-01282D5294B2
P2860
Meta-analysis of second-trimester markers for trisomy 21.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Meta-analysis of second-trimester markers for trisomy 21.
@ast
Meta-analysis of second-trimester markers for trisomy 21.
@en
Meta-analysis of second-trimester markers for trisomy 21.
@nl
type
label
Meta-analysis of second-trimester markers for trisomy 21.
@ast
Meta-analysis of second-trimester markers for trisomy 21.
@en
Meta-analysis of second-trimester markers for trisomy 21.
@nl
prefLabel
Meta-analysis of second-trimester markers for trisomy 21.
@ast
Meta-analysis of second-trimester markers for trisomy 21.
@en
Meta-analysis of second-trimester markers for trisomy 21.
@nl
P2093
P2860
P31
P356
P1476
Meta-analysis of second-trimester markers for trisomy 21
@en
P2093
K H Nicolaides
L C Y Poon
M Agathokleous
P Kosinski
P2860
P304
P356
10.1002/UOG.12364
P577
2013-01-24T00:00:00Z